FutraMed
The highly effective and disruptive FutraMed Limoge TCES device is the non-pharmaceutical solution for opioid (prescription pain killers/heroin) dependency..
- Stage Full Product Ready
- Industry Medical Devices and Equipment
- Location Sandy, UT, US
- Currency USD
- Founded December 2011
- Employees 5
- Website futramed.com
Company Summary
The FutraMed Limoge TCES device is a cutting edge technology that brings a non-pharmaceutical treatment to opioid addiction (pain killers and heroin).
Prescription opioid abuse is a growing epidemic in the US and internationally. Current treatments for opioid addiction are “replacement” pharmaceutical opioids such as methadone and buprenorphine that have devistating side effects. They do not free one from addiction. The Limoge TCES does.
Team
-
Matthew HardingPresident FutraMed EuropaMatthew Harding, President FutraMed Europa BA, MA, is a successful international entrepreneur who
has a background in clinical research. He currently resides in Spain and provides a link between FutraMed
USA and FutraMed Europa. -
President/CEOStephen Sahlin, President/CEO, BA, MA, is an accomplished sales professional in the medical field with significant management, strategic planning and training experience. Steve has highly successful outside sales experience with Fortune 500 companies and small international firms. He has proven expertise in working with corporate executives, surgeons, hospital systems and military purchasing.
-
Mike DrakeDirector of Regulatory/QualityMike is a QA professional who has implemented all aspects of quality and regulatory systems in the US and abroad. Mike has extensive knowledge of statistical applications, particularly in experimental design for research and manufacturing.
-
Ralph HattonDirector of EngineeringRalph has a BS in Engineering. He has a comprehensive understanding of the engineering process. He also has had a successful sales career with several major
corporations. -
Lynn SatterthwaiteClinical DirectorLynn has extensive experience in medical device firmmanagement and
taking products from inception to a marketable device. Satterthwaite has regulatory experience in obtaining the necessary clearances for multiple devices. He is active in new product designs and has obtained patents for these devices.
Advisors
-
Dr. Theodore (Ted) StanleyAdvisory BoardUnconfirmed
Previous Investors
-
James JohnstonUnconfirmed
Douglas HardingUnconfirmed
Clark TurnerUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.